Skip to main content
. 2019 May 20;10:543. doi: 10.3389/fphar.2019.00543

FIGURE 7.

FIGURE 7

c-Abl expression in the STZ-induced neuropathic pain model. (A) STZ and GNF-2 were administered intraperitoneally as shown in the experimental outline. (B) The expression of c-Abl mRNA in the spinal cord tissues after STZ injection was evaluated by conventional RT-PCR. (C) Quantification for the mRNA expression is displayed as fold change of gene expression normalized to GAPDH. (D) Glial expression of c-Abl (arrows) was confirmed by co-staining with GFAP, a marker of astrocyte GFAP (an astrocyte marker). p < 0.05 vs. vehicle-treated control animals; #p < 0.05 between the indicated groups; unpaired two-tailed Student’s t test; n = 3 for each group; data are represented as mean ± SEM. Scale bar, 100 and 200 μm.